Jane Street’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-29,404
| Closed | -$172K | – | 6646 |
|
|
2022
Q4 | $172K | Buy |
29,404
+18,992
| +182% | +$111K | ﹤0.01% | 4472 |
|
|
2022
Q3 | $70K | Buy |
+10,412
| New | +$70K | ﹤0.01% | 5012 |
|
|
2022
Q2 | – | Sell |
-16,627
| Closed | -$56K | – | 6573 |
|
|
2022
Q1 | $56K | Buy |
+16,627
| New | +$56K | ﹤0.01% | 5120 |
|
|
2021
Q3 | – | Sell |
-26,404
| Closed | -$111K | – | 6176 |
|
|
2021
Q2 | $111K | Buy |
+26,404
| New | +$111K | ﹤0.01% | 4712 |
|
|
2020
Q4 | – | Sell |
-16,647
| Closed | -$163K | – | 4589 |
|
|
2020
Q3 | $163K | Buy |
+16,647
| New | +$163K | ﹤0.01% | 3306 |
|
|
2018
Q1 | – | Sell |
-17,421
| Closed | -$451K | – | 3746 |
|
|
2017
Q4 | $451K | Buy |
+17,421
| New | +$451K | ﹤0.01% | 2118 |
|
|
2015
Q2 | – | Sell |
-20,330
| Closed | -$308K | – | 2944 |
|
|
2015
Q1 | $308K | Buy |
+20,330
| New | +$308K | ﹤0.01% | 1730 |
|